Adicet Bio, Inc. (LON: 0HX7)
London
· Delayed Price · Currency is GBP · Price in USD 0.886
-0.027 (-2.93%)
Jan 31, 2025, 6:47 PM BST
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of 58.67 million as of January 31, 2025. Its market cap has decreased by -37.17% in one year.
Market Cap
58.67M
Enterprise Value
-89.25M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.89
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from 232.15M to 58.67M, a decrease of -74.73%. That is a compound annual growth rate of -26.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 58.67M | -7.34% |
| Dec 31, 2024 | 63.32M | -1.14% |
| Dec 29, 2023 | 64.05M | -79.86% |
| Dec 30, 2022 | 317.95M | -37.12% |
| Dec 31, 2021 | 505.60M | 150.66% |
| Dec 31, 2020 | 201.71M | -13.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.43B |
| GSK plc | 57.21B |
| Haleon | 34.01B |
| Smith & Nephew | 9.00B |
| ConvaTec Group | 5.10B |
| Hikma Pharmaceuticals | 5.06B |
| HUTCHMED (China) | 1.88B |
| Oxford Nanopore Technologies | 1.38B |